Group 1 - The company has revised its Articles of Association, Shareholders' Meeting Rules, and Board Meeting Rules, with the cancellation of the Supervisory Board pending shareholder approval [11][13][15] - The company will hold a second extraordinary general meeting on September 16, 2025, to vote on the proposed changes and other matters [22][44] Group 2 - The company board has approved the nomination of Zhang Zheng as a non-independent director, subject to shareholder approval [17][36] - The board meeting held on August 28, 2025, was attended by all seven directors, and all resolutions were passed unanimously [8][21] Group 3 - The company has approved the 2025 semi-annual report and internal control self-evaluation report, which will be published on the Shanghai Stock Exchange [9][10][27][28] - The board has authorized the management to handle the specific implementation of land storage matters related to the Dragon Wu Road project [19][38]

Meeting Overview - The ninth meeting of the supervisory board of Shanghai Jiaoyun Group Co., Ltd. was held on August 18, 2025, in accordance with relevant laws and regulations [1] - The meeting was chaired by He Minghui, and all resolutions were passed with a unanimous vote of 3 in favor, 0 against, and 0 abstentions [1] Financial Report Review - The supervisory board conducted a thorough review of the 2025 semi-annual report, confirming that the preparation and review processes complied with legal and regulatory requirements [1] - The report was deemed to accurately reflect the company's financial and operational status for the first half of 2025, with no false statements or omissions identified [1] Internal Control Evaluation - The supervisory board reviewed the internal control self-assessment report for the first half of 2025, finding it to be objective and truthful regarding the company's internal control situation [2] - The voting results for this evaluation were also unanimous, with 3 votes in favor, 0 against, and 0 abstentions [2] Amendments to Company Regulations - The supervisory board approved amendments to the company's articles of association, including the cancellation of the supervisory board, transferring its legal powers to the audit committee of the board of directors [2][3] - The amendments to the rules of the shareholders' meeting and the board meeting were also approved, with unanimous voting results [3][4] Director Appointment - Zhang Zheng was confirmed to meet the qualifications for serving as a non-independent director, with no disqualifications or penalties from regulatory bodies [4] - This appointment will also be submitted for approval at the upcoming shareholders' meeting [4] Upcoming Shareholders' Meeting - The company plans to hold its second extraordinary shareholders' meeting of 2025 on September 16, 2025, using a combination of on-site voting and online voting [4]

Core Viewpoint - The company has established an internal control self-evaluation management system to enhance and standardize its internal control self-evaluation work, ensuring effective operation and timely identification of internal control deficiencies [1][2]. Group 1: Internal Control Self-Evaluation - Internal control self-evaluation refers to the comprehensive assessment of the effectiveness of the company's internal controls by the board of directors and management, leading to the formation of evaluation conclusions and reports [1]. - The effectiveness of internal control includes both design effectiveness and operational effectiveness, ensuring that necessary internal control elements are present and appropriately designed [1][2]. - The internal control self-evaluation applies to the company and its subsidiaries, including branches and wholly-owned or controlled subsidiaries [1]. Group 2: Risks and Principles - The company must focus on several risks during the internal control self-evaluation, including organizational structure issues, scientific evaluation methods, diligence of evaluation personnel, and professional skill levels [2]. - The evaluation should adhere to principles of comprehensiveness, importance, and objectivity, covering all business units and high-risk areas [2][3]. Group 3: Organizational Structure - The board of directors is ultimately responsible for the authenticity of the internal control self-evaluation report [3]. - The audit committee oversees the organization, leadership, and supervision of the internal control self-evaluation, including reviewing and approving rectification opinions for significant deficiencies [3][4]. - The general manager is responsible for organizing and implementing the internal control self-evaluation work and ensuring a conducive environment for its execution [4]. Group 4: Evaluation Content and Procedures - The internal control self-evaluation should encompass all significant operational aspects and relevant regulations throughout the company's activities [5][6]. - The annual evaluation process includes developing a work plan, conducting self-assessments, and compiling reports for review by the audit committee and board of directors [5][6]. Group 5: Deficiency Recognition - Internal control deficiencies are categorized into design deficiencies and operational deficiencies, further classified into major, important, and general deficiencies based on their impact [7][8]. - The audit committee is responsible for compiling a summary of recognized deficiencies and proposing corrective measures [7][8]. Group 6: Reporting - The internal control self-evaluation report must include elements such as the board's declaration of the report's authenticity, overall evaluation status, basis and scope of evaluation, identified deficiencies, and corrective measures [8][9]. - The report is to be submitted to the board of directors for approval and subsequently disclosed or sent to relevant departments [9][10].

Core Viewpoint - The supervisory board of Hualan Biological Engineering Co., Ltd. held its 15th meeting of the 8th session, approving several key proposals including the annual report, profit distribution plan, and changes in accounting policies, all of which will be submitted for shareholder approval at the upcoming annual general meeting [1][2][3]. Meeting Overview - The meeting was held on March 28, 2025, with all three supervisory board members present, complying with legal and regulatory requirements [1]. Resolutions Passed - The supervisory board approved the 2024 Annual Work Report, which will be submitted for shareholder review [2]. - The 2024 Annual Report and its summary were also approved, confirming that the report accurately reflects the company's situation without any misleading statements [2]. - The 2024 Financial Settlement Report was approved, pending shareholder approval [2]. - A profit distribution plan was approved, proposing a cash dividend of 2 yuan per 10 shares, totaling approximately 365.76 million yuan, with remaining undistributed profits rolling over to the next year [2][3]. - Changes to accounting policies and estimates were approved, ensuring compliance with the latest accounting standards without significantly impacting the company's financial status [3][4]. - The 2024 Internal Control Self-Evaluation Report was approved, indicating a robust internal control system in place [4]. - The proposal to use idle funds for investment and financial management was approved, aimed at improving fund utilization efficiency [5]. - The reappointment of the auditing firm for 2025 was approved, pending shareholder approval [5]. - The proposal to repurchase and cancel certain restricted stock options from the 2023 incentive plan was approved, ensuring compliance with relevant regulations [6]. - A proposal to amend the company's registered capital and related articles in the Articles of Association was approved, pending shareholder approval [6][7]. - The establishment of a Public Opinion Management System and a Market Value Management System was approved [7].

Core Points - The company held the 19th meeting of the sixth Supervisory Board on March 26, 2025, where several key resolutions were passed regarding the 2024 annual reports and financial matters [1][2][3]. Group 1: Supervisory Board Resolutions - The Supervisory Board approved the 2024 Annual Work Report, which will be submitted to the 2024 Annual General Meeting for review [1]. - The 2024 Financial Settlement Report was also approved, reflecting the company's actual operating conditions [1]. - The company will recognize an asset impairment provision totaling 701.48 million yuan for 2024, which includes previously disclosed impairments [1]. - The 2024 Annual Report and its summary were approved, confirming that the reports accurately reflect the company's situation [1]. - The profit distribution plan for 2024 was approved, with a net profit of approximately 2.67 billion yuan attributable to shareholders [1]. Group 2: Financial and Operational Plans - The company plans to apply for a comprehensive credit limit of up to 38 billion yuan for 2025 to support its operations [6]. - A proposal to use up to 5 billion yuan of self-owned funds for entrusted wealth management in 2025 was approved [7]. - The company will engage in financial derivatives trading with a total limit of up to 6 billion USD in 2025 to manage foreign exchange risks [9]. - The company will provide guarantees for certain subsidiaries with a total limit of up to 4.03 billion yuan [12]. - The company plans to support its subsidiary, Goertek Optical Technology, with financial assistance of up to 1 billion yuan [15]. Group 3: Internal Control and Governance - The company conducted a self-evaluation of its internal control for 2024, which was approved by the Supervisory Board [6]. - The internal control system was deemed adequate and compliant with relevant laws and regulations [6]. - The company updated its internal control system to enhance management and risk prevention capabilities [19].